Clinical Trials on 转甲状腺素蛋白淀粉样变性心脏病 in United States
总计2434个结果
-
University of FloridaNovartis Pharmaceuticals撤销
-
Yale UniversityBristol-Myers Squibb; National Cancer Institute (NCI)撤销
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science University; Taiho Oncology, Inc.招聘中
-
City of Hope Medical CenterNational Cancer Institute (NCI)终止复发性成人急性髓性白血病 | 伴有 11q23 (MLL) 异常的成人急性髓性白血病 | 伴有 Del(5q) 的成人急性髓性白血病 | 成人急性髓性白血病伴 Inv(16)(p13;q22) | 成人急性髓性白血病伴 t(16;16)(p13;q22) | 成人急性髓性白血病伴 t(8;21)(q22;q22) | 继发性急性髓性白血病 | 未经治疗的成人急性髓性白血病 | 成人急性髓性白血病伴 t(15;17)(q22;q12)美国
-
M.D. Anderson Cancer CenterIntrexon Corporation终止
-
National Cancer Institute (NCI)完全的复发性成人急性髓性白血病 | 伴有 11q23 (MLL) 异常的成人急性髓性白血病 | 伴有 Del(5q) 的成人急性髓性白血病 | 成人急性髓性白血病伴 Inv(16)(p13;q22) | 成人急性髓性白血病伴 t(16;16)(p13;q22) | 成人急性髓性白血病伴 t(8;21)(q22;q22) | 未经治疗的成人急性髓性白血病 | 成人急性髓性白血病伴 t(15;17)(q22;q12)美国
-
National Cancer Institute (NCI)完全的复发性成人急性髓性白血病 | 伴有 11q23 (MLL) 异常的成人急性髓性白血病 | 成人急性髓性白血病伴 Inv(16)(p13;q22) | 成人急性髓性白血病伴 t(16;16)(p13;q22) | 成人急性髓性白血病伴 t(8;21)(q22;q22) | 继发性急性髓性白血病 | 未经治疗的成人急性髓性白血病 | 成人急性髓性白血病伴 t(15;17)(q22;q12)美国
-
City of Hope Medical CenterNational Cancer Institute (NCI)撤销
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)撤销
-
GE HealthcareMedpace, Inc.; i3 Statprobe完全的
-
University of Colorado, DenverKaryopharm Therapeutics Inc招聘中
-
University of Maryland, BaltimoreHematologics, Inc招聘中
-
Washington University School of MedicineNational Institutes of Health (NIH); National Institute on Aging (NIA)完全的
-
H. Lee Moffitt Cancer Center and Research InstituteFlorida Department of Health招聘中
-
Brian JonasNational Cancer Institute (NCI); GlycoMimetics Incorporated招聘中
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy, Baylor College...招聘中
-
M.D. Anderson Cancer CenterEli Lilly and Company; High Impact Clinical Research Support Program完全的
-
H. Lee Moffitt Cancer Center and Research InstituteESP Pharma终止
-
Seattle Children's Hospital2seventy bio招聘中
-
Mayo ClinicNational Cancer Institute (NCI)终止继发性急性髓性白血病 | 未经治疗的成人急性髓性白血病 | 具有 FLT3/ITD 突变的急性髓性白血病 | 具有基因突变的急性髓性白血病 | FLT3 酪氨酸激酶结构域点突变美国
-
Washington University School of MedicineNational Cancer Institute (NCI); National Institutes of Health (NIH); Janssen Pharmaceuticals终止
-
Dana-Farber Cancer InstituteThe Leukemia and Lymphoma Society主动,不招人
-
University of Southern CaliforniaNational Cancer Institute (NCI)撤销
-
Milton S. Hershey Medical CenterTakeda; Millennium Pharmaceuticals, Inc.终止